BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 4554480)

  • 1. Cardiovascular and renal actions of dopamine: potential clinical applications.
    Goldberg LI
    Pharmacol Rev; 1972 Mar; 24(1):1-29. PubMed ID: 4554480
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine--clinical uses of an endogenous catecholamine.
    Goldberg LI
    N Engl J Med; 1974 Oct; 291(14):707-10. PubMed ID: 4604342
    [No Abstract]   [Full Text] [Related]  

  • 3. Dopamine for treatment of shock.
    Med Lett Drugs Ther; 1975 Feb; 17(4):13-4. PubMed ID: 1128445
    [No Abstract]   [Full Text] [Related]  

  • 4. [The fundamentals of dopamine. A new concept in the treatment of shock states].
    Ann Anesthesiol Fr; 1976; 17(10):VI-VIII. PubMed ID: 14558
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical trial of dopamine in the treatment of shock].
    Lauro E; Zeni L
    Minerva Anestesiol; 1977 Mar; 43(5):307-22. PubMed ID: 876471
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of phentolamine on the cardiovascular effects of dopamine in experimental cardiogenic shock.
    Bagwell EE; Daniell HB; Freeman BF
    Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):197-203. PubMed ID: 4852444
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular and renal action of dopaminergic prodrugs.
    Casagrande C; Merlo L; Ferrini R; Miragoli G; Semeraro C
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S40-59. PubMed ID: 2483441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the cardiovascular, renal, and coronary effects of dopamine and monensin in endotoxic shock.
    Somani P; Saini RK
    Circ Shock; 1981; 8(4):451-64. PubMed ID: 7023738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral and coronary vascular effects of a symmetrical N,N'-disubstituted hexahydrodiazepine.
    Buyniski JP; Losada M; Bierwagen ME; Gardier RW
    J Pharmacol Exp Ther; 1972 Jun; 181(3):522-8. PubMed ID: 5033017
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cardiovascular effects of glucagon].
    Lavarenne J
    Therapie; 1974; 29(2):161-84. PubMed ID: 4368071
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cardiovascular action of m-nisoldipine in anaesthetized rabbits and guinea pigs].
    Ren LM; Li YS; Fu SX; Jin CJ
    Zhongguo Yao Li Xue Bao; 1988 Sep; 9(5):426-30. PubMed ID: 3218537
    [No Abstract]   [Full Text] [Related]  

  • 12. L-dopa: its effect on the cardiovascular system.
    Carrasco HA; Lozano J; Lang TW; Meerbaum S
    Geriatrics; 1971 Sep; 26(9):100-8. PubMed ID: 5125691
    [No Abstract]   [Full Text] [Related]  

  • 13. Physiologic basis for the therapeutic use of catecholamines.
    Rosenblum R
    Am Heart J; 1974 Apr; 87(4):527-30. PubMed ID: 4817111
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mode of action and possibilities of use of dopamine].
    Weidner A
    ZFA (Stuttgart); 1977 Jan; 53(1):35-42. PubMed ID: 842100
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cardiovascular effects of hydroxytyramine (dopamine) and its importance for the therapy of cardiogenic shock in heart infarct. 2. Experimental studies on hypodynamic hearts of dogs].
    Urbaszek W; Günther K; Trenckmann H; Döring D
    Z Gesamte Inn Med; 1970 Apr; 25(7):290-3. PubMed ID: 4398843
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of cerebroventricular administration of ouabain on renal hemodynamics in anesthetized dogs: evidence for the participation of renal dopaminergic vasodilator fibers.
    Hom GJ; Jandhyala BS
    J Pharmacol Exp Ther; 1984 Aug; 230(2):275-83. PubMed ID: 6747837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dopamine in treatment of acute severe heart insufficiency].
    Ramdohr B; Biamino G; Schŭren KP; Schrŏder R
    Med Welt; 1975 Mar; 26(12):540-7. PubMed ID: 1134291
    [No Abstract]   [Full Text] [Related]  

  • 18. Systemic hemodynamic and regional blood flow effects of LY141865, a selective dopamine receptor agonist.
    Hahn RA; MacDonald BR
    J Pharmacol Exp Ther; 1984 Sep; 230(3):558-68. PubMed ID: 6470973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal and vascular actions of dopamine and their clinical significance.
    Louis WJ; Sampson R
    Prog Biochem Pharmacol; 1974; 9():22-8. PubMed ID: 4438380
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of N-cycloalkylation on the cardiovascular activity of noradrenalone.
    Chang LC; Cobbin LB
    Arch Int Pharmacodyn Ther; 1972 Jun; 197(2):224-35. PubMed ID: 4113163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.